Meanwhile, SC66 induced changes in cytoskeletal organization and ROS production, resulting in phosphorylated AKT level was notably decreased, and demonstrated that SC66 remarkably inhibit tumor growth via AKT/mTOR/β-catenin pathway in hepatocellular carcinoma (Cusimano et al., 2015). This evidence concerns the gene AKT1 and hepatocellular carcinoma.